Phase IIIAndrogen Modulator
Compound 61640
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061640
Risk Class
LOW
Last Audit
May 20, 2108
Research Abstract
Androgen Modulator candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61640 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase iii with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061640 with updates logged 2108-05-20.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61640Androgen Modulator Program 61640
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061640
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61640